Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

ETHSX Eaton Vance Worldwide Health Sci A

  • Fund
  • ETHSX
  • Price as of: May 21, 2019
  • $11.13 + $0.08 + 0.72%
  • Category
  • Health & Biotech Equities

ETHSX - Profile

Vitals

  • YTD Return 7.2%
  • 3 Yr Annualized Return 0.2%
  • 5 Yr Annualized Return -1.4%
  • Net Assets $998 M
  • Holdings in Top 10 42.3%

52 WEEK LOW AND HIGH

$11.13
$9.77
$11.97

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.06%

SALES FEES

  • Front Load 5.75%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 37.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$1,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 7.2%
  • 3 Yr Annualized Total Return 5.3%
  • 5 Yr Annualized Total Return 6.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.31%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Eaton Vance Worldwide Health Sciences Fund
  • Fund Family Name Eaton Vance
  • Inception Date Jul 26, 1985
  • Shares Outstanding 62624208
  • Share Class A
  • Currency USD
  • Domiciled Country United States
  • Manager Jason A. Kritzer

Fund Description

The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It has a policy of investing at least 25% of its assets in investments in the medical research and health care industry.

ETHSX - Performance

Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 7.2% -4.3% 27.1% 55.88%
1 Yr 5.6% -23.4% 7.2% 6.86%
3 Yr 0.2%* -16.9% 24.9% 77.45%
5 Yr -1.4%* -11.4% 18.4% 72.45%
10 Yr 3.7%* -1.8% 16.1% 86.42%

* Annualized


Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2018 0.8% -25.3% 7.7% 10.78%
2017 13.1% -10.8% 43.9% 63.73%
2016 -24.6% -29.8% 2.6% 95.10%
2015 -1.4% -20.4% 13.8% 41.18%
2014 9.0% -5.8% 31.5% 72.45%

Total Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 7.2% -4.3% 27.1% 55.88%
1 Yr 5.6% -23.4% 11.3% 14.71%
3 Yr 5.3%* -16.9% 28.1% 60.78%
5 Yr 6.9%* -11.4% 20.4% 38.78%
10 Yr 12.8%* -1.8% 18.6% 45.68%

* Annualized


Total Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2018 0.8% -25.3% 12.3% 18.63%
2017 16.2% -10.8% 45.8% 66.67%
2016 -14.8% -24.2% 8.7% 62.75%
2015 8.6% -16.6% 15.2% 23.53%
2014 27.2% -5.8% 36.7% 33.67%

NAV & Total Return History

ETHSX - Holdings

Concentration Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Assets 998 M 13.9 M 44.3 B 60.78%
Number of Holdings 62 28 362 77.45%
Net Assets in Top 10 441 M 7.98 M 18.8 B 61.76%
Weighting of Top 10 42.30% 24.7% 76.6% 46.08%

Top 10 Holdings

  1. Johnson & Johnson 7.17%

  2. Merck & Co Inc 5.94%

  3. Novartis AG 5.07%

  4. UnitedHealth Group Inc 4.28%

  5. Abbott Laboratories 3.99%

  6. Eli Lilly and Co 3.53%

  7. Pfizer Inc 3.45%

  8. GlaxoSmithKline PLC 3.28%

  9. Intuitive Surgical Inc 2.82%

  10. Anthem Inc 2.76%


Asset Allocation

Weighting Return Low Return High ETHSX % Rank
Stocks
99.58% 92.71% 99.87% 8.82%
Cash
0.42% 0.00% 7.28% 86.27%
Preferred Stocks
0.00% 0.00% 2.00% 50.00%
Other
0.00% -1.35% 3.29% 60.78%
Convertible Bonds
0.00% 0.00% 0.12% 38.24%
Bonds
0.00% 0.00% 0.09% 44.12%

Stock Sector Breakdown

Weighting Return Low Return High ETHSX % Rank
Healthcare
97.54% 13.80% 99.84% 16.67%
Technology
0.40% 0.00% 61.10% 64.71%
Utilities
0.00% 0.00% 0.00% 36.27%
Real Estate
0.00% 0.00% 2.13% 43.14%
Industrials
0.00% 0.00% 10.61% 58.82%
Financial Services
0.00% 0.00% 3.44% 50.00%
Energy
0.00% 0.00% 0.08% 39.22%
Communication Services
0.00% 0.00% 0.00% 36.27%
Consumer Defense
0.00% 0.00% 0.40% 44.12%
Consumer Cyclical
0.00% 0.00% 7.87% 50.98%
Basic Materials
0.00% 0.00% 0.47% 45.10%

Stock Geographic Breakdown

Weighting Return Low Return High ETHSX % Rank
US
71.88% 62.33% 99.20% 88.24%
Non US
27.70% 0.00% 37.50% 12.75%

ETHSX - Expenses

Operational Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.06% 0.10% 2.98% 67.65%
Management Fee 0.63% 0.09% 1.25% 31.37%
12b-1 Fee 0.25% 0.00% 1.00% 21.74%
Administrative Fee 0.15% 0.01% 0.40% 64.41%

Sales Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 2.50% 5.75% 25.93%
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.75% 2.00% N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 37.00% 0.00% 699.00% 48.04%

ETHSX - Distributions

Dividend Yield Analysis

ETHSX Category Low Category High ETHSX % Rank
Dividend Yield 0.00% 0.00% 0.01% 13.73%

Dividend Distribution Analysis

ETHSX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Annually Annually

Dividend Payout History


Net Income Ratio Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Income Ratio 0.31% -2.15% 1.48% 15.69%

Capital Gain Distribution Analysis

ETHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

ETHSX - Managers

Jason A. Kritzer

Manager

Start Date

Tenure

Tenure Rank

Jul 01, 2016

2.83

2.8%

Mr. Kritzer is a Vice President of Eaton Vance. Prior to joining Eaton Vance in 2012, Mr. Kritzer was a director and equity analyst at BlackRock , Inc. covering the healthcare sector since 2006.


Samantha Pandolfi

Manager

Start Date

Tenure

Tenure Rank

Jul 01, 2016

2.83

2.8%

Ms. Pandolfi is a Vice President of EVAIL. Prior to joining EVAIL, Ms. Pandolfi held similar positions at EVMI. Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure (2000-2015).


Tenure Analysis

Category Low

0.09

Category High

21.64

Category Average

10.34

Category Mode

19.01